Trying to separate three different claims about thymosin alpha-1: that it is the right molecule, that it is the right dose, and that it does something useful.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
Animal data is much of what exists here and the human stuff is thin and small.
Happy to be corrected on any of the above.
What is the first thing you would read if you were starting from zero?
What is the first thing you would read if you were starting from zero?
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
This board overrates bloodwork. A number moving is not the outcome you wanted. Injection site reaction was my main issue with thymosin alpha-1 too.
Nobody has ever been talked out of a stack by a stranger on the internet. Two months in on thymosin alpha-1 and it lines up.
Baseline first. How long have you been on thymosin alpha-1?
Nobody has ever been talked out of a stack by a stranger on the internet.
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid.
Stupid question: how do you know whether what is in the vial matches the label at all? Currently on thymosin alpha-1 myself.
Read methods.
Stupid question: how do you know whether what is in the vial matches the label at all?
Stupid question: how do you know whether what is in the vial matches the label at all? Not on thymosin alpha-1 but the pattern is familiar.
Cold storage, light protection, date on the vial. Boring, removes half the variables.
Nobody has ever been talked out of a stack by a stranger on the internet.